CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma
about
CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma
description
im November 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@en
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@nl
type
label
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@en
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@nl
prefLabel
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@en
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@nl
P2093
P2860
P921
P356
P1433
P1476
CRISPR/Cas9‑mediated hypoxia i ...... on in hepatocellular carcinoma
@en
P2093
Dickson Adah
Li-Ping Liu
Qiao-Ting Yan
Renyan Liu
Shi-Yun Bao
P2860
P304
P356
10.3892/OR.2018.6667
P407
P577
2018-11-01T00:00:00Z